Proteomic identification of prognostic tumour biomarkers, using chemotherapy-induced cancer-associated fibroblasts

Aging

Volumn 7, Issue 10, 2015, Pages 816-838

  Peiris Pagès, Maria ^a,b   Smith, Duncan L ^c   Gyorffy, Balázs ^d,e   Sotgia, Federica ^a,b   Lisanti, Michael P ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^e SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Cancer survival; Cancer associated fibroblasts; Catabolism; Chemotherapy; Markers; Metabolism; Quantitative proteomics; Second primary tumours; Tumour microenvironment

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; AZATHIOPRINE; PACLITAXEL; TUMOR MARKER;

AUTOPHAGY; CELL AGING; CELL CULTURE; CELL DIFFERENTIATION; DISEASE FREE SURVIVAL; DRUG EFFECTS; FIBROBLAST; HUMAN; METABOLISM; METASTASIS; PHYSIOLOGICAL STRESS; PROTEOMICS; TUMOR MICROENVIRONMENT; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; AUTOPHAGY; AZATHIOPRINE; BIOMARKERS, TUMOR; CELL AGING; CELL DIFFERENTIATION; CELLS, CULTURED; DISEASE-FREE SURVIVAL; FIBROBLASTS; HUMANS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PACLITAXEL; PROTEOMICS; STRESS, PHYSIOLOGICAL; TUMOR MICROENVIRONMENT;

EID: 84946218109     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100808     Document Type: Article

References (34)

1. Elkhattouti A, Hassan M and Gomez CR. Stromal Fibroblast in Age-Related Cancer: Role in Tumorigenesis and Potential as Novel Therapeutic Target. Frontiers in oncology. 2015; 5:158.
2. Lasry A and Ben-Neriah Y. Senescence-associated inflammatory responses: aging and cancer perspectives. Trends in immunology. 2015; 36:217-228.
3. Hanahan D and Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012; 21:309-322.
4. Lisanti MP, Sotgia F, Pestell RG, Howell A and Martinez-Outschoorn UE. Stromal glycolysis and MCT4 are hallmarks of DCIS progression to invasive breast cancer. Cell Cycle. 2013; 12:2935-2936.
5. Balliet RM, Capparelli C, Guido C, Pestell TG, Martinez-Outschoorn UE, Lin Z, Whitaker-Menezes D, Chiavarina B, Pestell RG, Howell A, Sotgia F and Lisanti MP. Mitochondrial oxidative stress in cancer-associated fibroblasts drives lactate production, promoting breast cancer tumor growth: understanding the aging and cancer connection. Cell Cycle. 2011; 10:4065-4073.
6. Bartling B, Hofmann HS, Silber RE and Simm A. Differential impact of fibroblasts on the efficient cell death of lung cancer cells induced by paclitaxel and cisplatin. Cancer Biol Ther. 2008; 7:1250-1261.
7. Ertel A, Tsirigos A, Whitaker-Menezes D, Birbe RC, Pavlides S, Martinez-Outschoorn UE, Pestell RG, Howell A, Sotgia F and Lisanti MP. Is cancer a metabolic rebellion against host aging? In the quest for immortality, tumor cells try to save themselves by boosting mitochondrial metabolism. Cell Cycle. 2012; 11:253-263.
8. Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, Romero IL, Carey MS, Mills GB, Hotamisligil GS, Yamada SD, Peter ME, Gwin K and Lengyel E. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med. 2011; 17:1498-1503.
9. Zhang W, Trachootham D, Liu J, Chen G, Pelicano H, Garcia-Prieto C, Lu W, Burger JA, Croce CM, Plunkett W, Keating MJ and Huang P. Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia. Nat Cell Biol. 2012; 14:276-286.
10. Sun Y, Campisi J, Higano C, Beer TM, Porter P, Coleman I, True L and Nelson PS. Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nature medicine. 2012; 18:1359-1368.
11. Peiris-Pagès MS, Sotgia F., Lisanti, MP. Chemotherapy induces the cancer-associated fibroblast phenotype, activating paracrine Hedgehog-GLI signaling in breast cancer cells. Oncotarget. 2015; 6:10728-10745.
12. Porter DC, Farmaki E, Altilia S, Schools GP, West DK, Chen M, Chang BD, Puzyrev AT, Lim CU, Rokow-Kittell R, Friedhoff LT, Papavassiliou AG, Kalurupalle S, Hurteau G, Shi J, Baran PS, et al. Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities. Proc Natl Acad Sci U S A. 2012; 109:13799-13804.
13. Karran, P. & Attard, N. Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer. Nat Rev Cancer. 2008; 8:24-36.
14. Raja FA, Chopra N and Ledermann JA. Optimal first-line treatment in ovarian cancer. Annals of oncology: official journal of the European Society for Medical Oncology / ESMO. 2012; 23 Suppl 10:x118-127.
15. Vyas D, Laput G and Vyas AK. Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis. OncoTargets and therapy. 2014; 7:1015-1023.
16. Gyorffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q and Szallasi Z. An online survival analysis tool to rapidly assess the effect of 22, 277 genes on breast cancer prognosis using microarray data of 1, 809 patients. Breast cancer research and treatment. 2010; 123:725-731.
17. Lopez-Otin C, Blasco MA, Partridge L, Serrano M and Kroemer G. The hallmarks of aging. Cell. 2013; 153:1194-1217.
18. Kumari KK and Setty OH. Protective effect of Phyllanthus fraternus against mitochondrial dysfunction induced by co-administration of cisplatin and cyclophosphamide. J Bioenerg Biomembr. 2012; 44:179-188.
19. Velez JM, Miriyala S, Nithipongvanitch R, Noel T, Plabplueng CD, Oberley T, Jungsuwadee P, Van Remmen H, Vore M and St Clair DK. p53 Regulates oxidative stress-mediated retrograde signaling: a novel mechanism for chemotherapy-induced cardiac injury. PLoS One. 2011; 6:e18005.
20. Paunescu V, Bojin FM, Tatu CA, Gavriliuc OI, Rosca A, Gruia AT, Tanasie G, Bunu C, Crisnic D, Gherghiceanu M, Tatu FR, Tatu CS and Vermesan S. Tumour-associated fibroblasts and mesenchymal stem cells: more similarities than differences. J Cell Mol Med. 2011; 15:635-646.
21. Desmouliere A, Darby IA and Gabbiani G. Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis. Lab Invest. 2003; 83:1689-1707.
22. Campisi J and d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nature reviews Molecular cell biology. 2007; 8:729-740.
23. Goehe RW, Di X, Sharma K, Bristol ML, Henderson SC, Valerie K, Rodier F, Davalos AR and Gewirtz DA. The autophagy-senescence connection in chemotherapy: must tumor cells (self) eat before they sleep? J Pharmacol Exp Ther. 2012; 343:763-778.
24. Martinez-Outschoorn UE, Whitaker-Menezes D, Lin Z, Flomenberg N, Howell A, Pestell RG, Lisanti MP and Sotgia F. Cytokine production and inflammation drive autophagy in the tumor microenvironment: role of stromal caveolin-1 as a key regulator. Cell Cycle. 2011; 10:1784-1793.
25. Grivennikov SI, Greten FR and Karin M. Immunity, inflammation, and cancer. Cell. 2010; 140:883-899.
26. Kamp DW, Shacter E and Weitzman SA. Chronic inflammation and cancer: the role of the mitochondria. Oncology. 2011; 25:400-410, 413.
27. Marin-Buera L, Garcia-Bartolome A, Moran M, Lopez-Bernardo E, Cadenas S, Hidalgo B, Sanchez R, Seneca S, Arenas J, Martin MA and Ugalde C. Differential proteomic profiling unveils new molecular mechanisms associated with mitochondrial complex III deficiency. Journal of proteomics. 2015; 113:38-56.
28. Lisanti MP, Martinez-Outschoorn UE, Pavlides S, Whitaker-Menezes D, Pestell RG, Howell A and Sotgia F. Accelerated aging in the tumor microenvironment: connecting aging, inflammation and cancer metabolism with personalized medicine. Cell cycle. 2011; 10:2059-2063.
29. Martinez-Outschoorn UE, Curry JM, Ko YH, Lin Z, Tuluc M, Cognetti D, Birbe RC, Pribitkin E, Bombonati A, Pestell RG, Howell A, Sotgia F and Lisanti MP. Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFkappaB target stromal MCT4. Cell Cycle. 2013; 12:2580-2597.
30. Lisanti MP, Martinez-Outschoorn UE, Lin Z, Pavlides S, Whitaker-Menezes D, Pestell RG, Howell A and Sotgia F. Hydrogen peroxide fuels aging, inflammation, cancer metabolism and metastasis: the seed and soil also needs "fertilizer". Cell cycle. 2011; 10:2440-2449.
31. Salata C, Ferreira-Machado SC, De Andrade CB, Mencalha AL, Mandarim-De-Lacerda CA and de Almeida CE. Apoptosis induction of cardiomyocytes and subsequent fibrosis after irradiation and neoadjuvant chemotherapy. International journal of radiation biology. 2014; 90:284-290.
32. Sampson N, Berger P and Zenzmaier C. Therapeutic targeting of redox signaling in myofibroblast differentiation and age-related fibrotic disease. Oxidative medicine and cellular longevity. 2012; 2012:458276.
33. Cat B, Stuhlmann D, Steinbrenner H, Alili L, Holtkotter O, Sies H and Brenneisen P. Enhancement of tumor invasion depends on transdifferentiation of skin fibroblasts mediated by reactive oxygen species. Journal of cell science. 2006; 119:2727-2738.
34. Scott AM, Wiseman G, Welt S, Adjei A, Lee FT, Hopkins W, Divgi CR, Hanson LH, Mitchell P, Gansen DN, Larson SM, Ingle JN, Hoffman EW, Tanswell P, Ritter G, Cohen LS, et al. A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clinical cancer research: an official journal of the American Association for Cancer Research. 2003; 9:1639-1647.